
Chemoinformatics Market Report 2026
Global Outlook – By Type (Chemistry, Computer Science, Information Science), By Application (Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications), By End User (Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Chemoinformatics Market Overview
• Chemoinformatics market size has reached to $4.33 billion in 2025 • Expected to grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 3.9% • Growth Driver: The Surging Prevalence Of Chronic Diseases Is Expected To Drive Chemoinformatic Market Growth • Market Trend: Innovative Digital Tools Accelerate Advances In Molecular Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Chemoinformatics Market?
Chemoinformatic refers to an emerging area of information technology that concentrates on the gathering, storing, analyzing, and manipulating of chemical data. It is further used to analyse the association between the target molecular activity, chemical characteristics, and structure. The main types of chemoinformatics are chemistry, computer science, and information science. Chemoinformatics is used in chemistry to comprehend the physical, chemical, and biological characteristics of various chemical compounds and to shorten the time needed to find prospective therapeutic targets. The various applications involved are chemical analysis, drug discovery and validation, virtual screening, and others that are used by chemical and pharmaceutical industries, research and academic institution, and other end users.
What Is The Chemoinformatics Market Size and Share 2026?
The chemoinformatics market size has grown steadily in recent years. It will grow from $4.33 billion in 2025 to $4.51 billion in 2026 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to growth of pharmaceutical r&d activities, increasing chemical data generation, rising adoption of computational chemistry tools, expansion of academic research programs, availability of chemical databases.What Is The Chemoinformatics Market Growth Forecast?
The chemoinformatics market size is expected to see steady growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to increasing investments in digital drug discovery, rising demand for faster molecular screening, expansion of precision medicine research, growing integration of machine learning models, increasing focus on cost-efficient r&d processes. Major trends in the forecast period include increasing use of ai in drug discovery analytics, rising adoption of virtual screening tools, growing integration of big data in chemical research, expansion of cloud-based chemoinformatics platforms, enhanced focus on predictive modeling.Global Chemoinformatics Market Segmentation
1) By Type: Chemistry, Computer Science, Information Science 2) By Application: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications 3) By End User: Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users Subsegments: 1) By Chemistry: Molecular Modeling, Chemical Database Management, Structure-Activity Relationship (SAR) Analysis 2) By Computer Science: Software Development for Chemoinformatics, Data Mining and Machine Learning Applications, Computational Chemistry Algorithms 3) By Information Science: Data Integration and Analysis, Knowledge Management in Chemical Research, Information Retrieval Systems for Chemical DataWhat Is The Driver Of The Chemoinformatics Market?
The surging prevalence of chronic diseases is expected to propel the growth of the chemoinformatic market going forward. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, in April 2025, according to the NHS Confederation, a UK-based national association, in 2035, it is estimated that 17% of the UK population could be living with four or more chronic conditions. Therefore, the surging prevalence of chronic diseases is driving the demand for the chemoinformatic industry.What Is The Driver Of The Chemoinformatics Market?
The surging prevalence of chronic diseases is expected to propel the growth of the chemoinformatic market going forward. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, in April 2025, according to the NHS Confederation, a UK-based national association, in 2035, it is estimated that 17% of the UK population could be living with four or more chronic conditions. Therefore, the surging prevalence of chronic diseases is driving the demand for the chemoinformatic industry.Global Chemoinformatics Market Trends and Insights
Major companies operating in the chemoinformatics market are focusing on developing innovative solutions such as molecular-modeling tools to accelerate drug discovery and improve predictive accuracy. Molecular-modeling tools are software applications that simulate the structure and behavior of molecules to help researchers predict chemical properties and design new compounds. For instance, in September 2023, Kode S.r.l., an Italy-based software engineering company, launched FAST to enhance the speed and efficiency of chemoinformatics workflows. The platform is designed to support rapid molecule analysis, property prediction, and data processing for research and development teams. By improving computational performance and usability, FAST helps organizations accelerate innovation in drug discovery and chemical informatics.What Are Latest Mergers And Acquisitions In The Chemoinformatics Market?
In October 2024, Certara Inc a US-based model-informed drug development company, acquired Chemaxon for an undisclosed amount. Through this acquisition, Certara aims to strengthen its drug discovery software portfolio by integrating Chemaxon’s cheminformatics tools, enhancing chemical structure analysis, property prediction, and data-driven decision-making capabilities. ChemAxon Ltd. is a US-based software company specializing in cheminformatics solutions for life sciences, biotechnology, and chemical research, offering tools for chemical structure drawing, in-silico screening, and predictive modeling to support research and development activities.Regional Insights
North America was the largest region in the chemoinformatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Chemoinformatics Market?
The chemoinformatic market includes revenues earned by entities by developing and providing chemoinformatic tools and software used in the data analysis and drug discovery processes by pharmaceuticals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Chemoinformatics Market Report 2026?
The chemoinformatics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chemoinformatics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Chemoinformatics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.51 billion |
| Revenue Forecast In 2035 | $5.25 billion |
| Growth Rate | CAGR of 4.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, OpenEye Scientific Software Inc., Schrödinger Inc., Advanced Chemistry Development Inc., Scilligence Corporation, Dassault Systèmes SE, Chemical Computing Group Inc., Collaborative Drug Discovery Inc., KNIME.COM Aktiengesellschaft, Simulations Plus Inc., Cambridgesoft Corp., Molecular Discovery Ltd., Optibrium Ltd., Cresset Group Ltd., Dotmatics Ltd., Genedata AG, Inte:Ligand GmbH, MolPort Inc., Cheminformatics LLC, Chemspace, InfoChem GmbH, Molecular Networks GmbH, VLife Sciences Technologies Pvt. Ltd., Xemistry GmbH, Cheminnovation Software Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
